827017-13-0

Upstream product

• 1477-50-5 Indole-2-carboxylic acid 
• 82211-90-3 4-(2,6-dichlorophenyl)piperidine 

Downstream Products

• 827016-63-7 2-[4-(2,6-dichloro-phenyl)-piperidin-1-ylmethyl]-1H-indole 
• 827016-83-1 2-(4-(2,6-dichlorophenyl)-piperidin-1-ylmethyl)-1-(2-hydroxyethyl)-1H-indole 
• 827016-80-8 1-benzyl-2-[4-(2,6-dichloro-phenyl)-piperidin-1-ylmethyl]-1H-indole 
• 827016-84-2 1-benzoyl-2-[4-(2,6-dichloro-phenyl)-piperidin-1-ylmethyl]-1H-indole 
• 827017-14-1 2-[4-(2,6-dichloro-phenyl)-piperidin-1-ylmethyl]-1H-indole hydrochloride 
• 827017-17-4 2-(4-(2,6-dichlorophenyl)-piperidin-1-ylmethyl)-1-(2-hydroxyethyl)-1H-indole hydrochloride 
• 827017-16-3 1-benzyl-2-[4-(2,6-dichloro-phenyl)-piperidin-1-ylmethyl]-1H-indole hydrochloride 

Relevant academic research and scientific papers

SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR

New ligands for the ORL-1 receptor are described, useful for modulating the activity of said receptors in a patient in need thereof, and for preventing and treating illnesses dependent on the stimulation of this receptor. The new compounds conform to structural formula (I), wherein Q is a moiety of formula (II) and R, R0, R1, R2, R3, R4, R5, R6 are further defined in the description.